| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥369.5B | ¥389.6B | -5.1% |
| Operating Income | ¥6.4B | ¥6.4B | -0.8% |
| Ordinary Income | ¥6.9B | ¥6.8B | +1.7% |
| Net Income | ¥-4.7B | ¥0.9B | -597.7% |
| ROE | -5.8% | 1.2% | - |
FY2025 results: Revenue 369.5B (YoY -5.1%), Operating Income 6.4B (-0.8%), Ordinary Income 6.9B (+1.7%), Net Income -4.7B (-597.7%). The company maintained operating profitability despite revenue decline but suffered significant net loss driven by impairment charges of 2.7B and elevated tax burden. Operating margin remained stable at 1.7% (gross margin 10.5%, SG&A ratio 8.8%). Asia segment contributed 56.0% of revenue at 218.3B with operating margin of 4.0%, significantly outperforming Japan segment's 2.4% margin. Operating cash flow strengthened substantially to 25.6B (+46.9% YoY), generating free cash flow of 19.2B despite capital expenditure of 8.3B. Balance sheet shows equity ratio of 28.3% with total assets of 287.7B and equity of 81.6B. Cash position improved to 53.8B (+25.2% YoY). Debt/EBITDA stands at 6.51x with short-term debt representing 62.3% of total liabilities, indicating refinancing pressure. Full-year forecast projects strong recovery with revenue of 410.0B (+10.9%) and operating income of 10.8B (+69.2%).
Revenue declined 5.1% to 369.5B driven by softness across major product categories. Automotive equipment sales decreased to 196.7B from prior year's stronger demand, while office equipment fell to 24.1B and industrial equipment to 42.0B. Medical equipment maintained relative stability at 39.4B. Geographic analysis shows Japan segment revenue of 171.2B with operating income of 4.2B (margin 2.4%), while Asia segment delivered 218.3B revenue with 8.7B operating income (margin 4.0%), demonstrating Asia's superior profitability and representing the core earnings driver. Cost of sales decreased proportionally to 330.8B (89.5% of revenue), maintaining gross margin at 10.5%. SG&A expenses declined to 32.4B (8.8% of revenue) from 35.6B prior year, reflecting cost control efforts that enabled operating income stability at 6.4B despite revenue headwinds. Non-operating results contributed positively with net non-operating income of 0.5B (non-operating income 3.0B including interest income 0.9B and equity method gains 0.1B, offset by non-operating expenses 2.5B including interest expense 2.0B and FX losses 0.3B). Extraordinary items created significant P&L volatility: extraordinary income of 1.8B (primarily gain on sale of securities 1.7B) was more than offset by extraordinary loss of 2.8B (impairment loss 2.7B). This 1.0B net extraordinary loss combined with income tax expense of 3.0B (effective tax rate 51.7% on pretax income of 5.9B) resulted in net loss of 4.7B despite positive ordinary income. The substantial gap between operating income (6.4B) and net loss (-4.7B) stems from high tax burden (3.0B) and net extraordinary losses (1.0B), highlighting earnings quality concerns from non-recurring factors and elevated tax expenses. Pattern: Revenue down, operating income flat, but net income sharply down due to tax burden and extraordinary losses.
Asia segment generated revenue of 218.3B (56.0% of total) with operating income of 8.7B and operating margin of 4.0%, representing the core business with highest profitability. Japan segment contributed 171.2B revenue (43.9%) with operating income of 4.2B and lower margin of 2.4%. The 160 basis point margin differential between Asia (4.0%) and Japan (2.4%) reflects Asia's superior operational efficiency and product mix. Asia's operating income of 8.7B accounts for 67.7% of total segment profit, confirming its role as the primary earnings engine. Japan segment profit contribution remains important but margins warrant improvement. North America operations classified as "Other" contributed minimal revenue of 0.9B with operating loss of 0.3B. Segment-level impairment losses were recorded in Japan (2.7B), materially impacting Japan segment profitability and explaining the divergence between segment operating income and consolidated results.
[Profitability] ROE of -5.8% reflects net loss impact, deteriorating from prior positive territory. Operating margin of 1.7% remained stable YoY at 1.7% (prior 1.7%), but gross margin of 10.5% remains structurally low, limiting operating leverage. EBIT margin of 1.7% and EBITDA margin of approximately 3.4% (EBIT 6.4B plus D&A 6.1B equals EBITDA 12.5B) indicate thin profitability cushion. Effective tax rate of 51.7% is abnormally high and warrants monitoring. [Efficiency] Asset turnover of 1.28x (revenue 369.5B / average assets 288.7B) shows moderate asset utilization. Accounts receivable of 78.9B implies DSO of approximately 78 days, suggesting extended collection cycles. Inventory of 7.6B (finished goods 7.6B, WIP 2.9B, raw materials 56.3B total inventory including raw materials classified separately) represents limited inventory days relative to COGS. [Financial Health] Equity ratio of 28.3% indicates high leverage with debt/equity ratio of 2.53x. Current ratio of 135.2% and quick ratio of 130.8% provide adequate short-term liquidity. Interest-bearing debt totals 81.5B (short-term loans 50.8B, current portion of long-term debt 35.0B, long-term loans 30.7B), with debt/EBITDA of 6.51x reflecting elevated leverage. Interest coverage ratio of 3.14x (EBIT 6.4B / interest expense 2.0B) provides limited margin of safety. Net debt position of 27.7B (gross debt 81.5B less cash 53.8B) represents 3.4x equity. [Cash Quality] Cash and equivalents of 53.8B increased 25.2% YoY, covering 1.06x short-term debt obligations. Operating cash flow of 25.6B significantly exceeds net income, yielding OCF/net income ratio of 13.9x, indicating strong cash-based earnings quality despite reported loss.
Operating cash flow of 25.6B represents 3.94x EBITDA of 6.5B (operating income 6.4B plus D&A 6.1B), demonstrating robust cash conversion well above the quality threshold. The substantial OCF improvement of 46.9% YoY from 17.4B prior year reflects enhanced working capital management, particularly inventory decrease of 12.6B and receivables decrease of 5.4B, partially offset by payables decrease of 4.7B. Operating CF before working capital changes was 27.4B, with working capital providing net positive contribution of 13.3B. Income taxes paid of 1.9B were modest relative to tax expense of 3.0B, suggesting timing differences. Investing cash flow of -6.5B consisted primarily of capital expenditure of 8.3B, partially offset by proceeds from sale of investment securities of 2.9B. The CapEx/depreciation ratio of 1.36x (8.3B / 6.1B) indicates growth-oriented investment above maintenance levels. Intangible asset purchases of 0.95B supplement CapEx. Free cash flow of 19.2B (OCF 25.6B less CapEx 8.3B less intangible CapEx 0.95B) provides substantial financial flexibility. Financing cash flow of -9.2B reflected debt management activities: long-term loan proceeds of 19.3B were offset by repayments of 19.5B, while short-term loans decreased 6.9B, resulting in net debt reduction. Dividends paid of 0.9B and share repurchases of 0.7B totaling 1.6B represent modest shareholder returns covered 12.0x by FCF. Cash position increased 10.6B to 53.6B after foreign exchange effects of 0.7B, strengthening liquidity buffer against short-term debt obligations of 50.8B.
Ordinary income of 6.9B versus operating income of 6.4B shows net non-operating contribution of 0.5B, representing 7.2% of operating income and comprising primarily interest income 0.9B and equity method income 0.1B, partially offset by interest expense 2.0B and FX losses 0.3B. The non-operating contribution is modest and derives from core financial activities. Extraordinary items totaling net loss of 1.0B (extraordinary income 1.8B less extraordinary loss 2.8B) represent non-recurring factors equivalent to 15.6% of operating income. Impairment loss of 2.7B recognized primarily in Japan segment constitutes a significant one-time charge reducing earnings quality. Gain on sale of investment securities of 1.7B partially offsets this but remains non-recurring. The substantial variance between ordinary income (6.9B) and net income (-4.7B) stems from pretax income of 5.9B (after extraordinary items) being reduced by income tax expense of 3.0B (51.7% effective rate) and non-controlling interests of 1.0B. Operating cash flow of 25.6B substantially exceeds operating income of 6.4B by 4.0x, indicating healthy cash-backed earnings, though this ratio is inflated by working capital benefits. Adjusting for D&A of 6.1B, EBITDA of 12.5B compares to OCF of 25.6B with the difference primarily explained by favorable working capital changes of 13.3B. Core earnings quality benefits from strong operating cash generation, but is impaired by significant non-recurring charges, elevated tax burden, and reliance on working capital inflows that may not be sustainable.
Full-year revenue guidance of 410.0B represents 10.9% growth from FY2025 actual of 369.5B, while operating income forecast of 10.8B implies 69.2% increase from 6.4B actual. Ordinary income guidance of 9.8B reflects 41.8% growth from 6.9B. Net income attributable to owners forecast of 7.1B would reverse the FY2025 loss of 4.7B. Progress assessment is not applicable as this represents initial full-year guidance without interim period benchmarks. The ambitious operating income growth of 69.2% on revenue growth of 10.9% implies operating leverage improvement with forecasted operating margin of 2.6% versus actual 1.7%, representing 90bp expansion. This suggests expectations for gross margin improvement, operating expense leverage, or product mix enhancement. EPS forecast of 106.91 on net income of 7.1B implies approximately 66.4M shares outstanding. The forecast assumes normalization of tax burden from FY2025's abnormal 51.7% effective rate and absence of significant extraordinary losses. Dividend forecast of 8.00 per share represents payout ratio of 7.5% against forecasted EPS of 106.91, indicating conservative distribution policy while rebuilding profitability. Key assumptions per forecast notes include current information and reasonable premises subject to significant variability, requiring monitoring of Asia demand recovery, operational efficiency gains, and tax normalization for forecast achievement.
Annual dividend of 16.00 per share consists of interim dividend of 6.00 and year-end dividend of 6.00, maintaining consistent distribution despite net loss. The dividend represents payout ratio of 29.2% as reported in XBRL data, though this appears calculated against a different earnings base than the reported net loss, potentially using normalized or core earnings. Against basic EPS of 27.75, dividend of 16.00 implies payout ratio of 57.7%, which is elevated but sustainable given strong operating cash flow of 25.6B covering total dividend payments of approximately 1.1B by 23.3x. Share repurchases of 0.7B supplement dividends, bringing total shareholder returns to approximately 1.8B for implied total return ratio of approximately 38% against reported net income base, though this calculation is distorted by the net loss. On an OCF basis, total returns of 1.8B represent 7.0% of operating cash flow, indicating conservative capital allocation prioritizing balance sheet strengthening and growth investment. For FY2026, dividend forecast of 8.00 per share represents decrease from FY2025's 16.00, likely reflecting reset expectations and alignment with normalized earnings, with forecasted payout ratio of 7.5% against EPS projection of 106.91 indicating shift toward earnings retention for growth and debt reduction.
Geographic concentration risk with Asia segment representing 56.0% of revenue and 67.7% of operating profit exposes the company to regional economic cycles, geopolitical tensions, and supply chain disruptions in Asian markets, particularly affecting automotive and electronics sectors. Extended accounts receivable cycle with DSO of approximately 78 days creates working capital pressure and credit risk exposure of 78.9B in trade receivables, representing 27.4% of total assets, with potential for bad debt losses if customer financial conditions deteriorate or collection management weakens. Refinancing risk from high short-term debt concentration of 62.3% (short-term loans 50.8B plus current portion of long-term debt 35.0B equals 85.8B short-term obligations against total debt of 81.5B, noting overlap in classification) combined with debt/EBITDA of 6.51x creates vulnerability to interest rate increases and credit market tightening, with interest coverage of only 3.14x providing limited cushion if operating performance weakens.
[Industry Position] (Reference - Proprietary Analysis)
The company operates in the electronics manufacturing services (EMS) sector with concentration in automotive electronics, office equipment, industrial equipment, and medical devices assembly. Profitability metrics show operating margin of 1.7% which is at the lower end of typical EMS industry ranges of 2-5%, reflecting intense price competition and low-margin contract manufacturing characteristics. The company's Asia-centric production footprint aligns with industry trends but creates concentration risk. Debt/EBITDA of 6.51x exceeds typical industry comfort levels of 3-4x, positioning the company in the higher leverage quartile within the sector. Operating cash flow margin of 6.9% (OCF 25.6B / revenue 369.5B) demonstrates relatively strong cash conversion typical of working-capital-intensive manufacturing operations. The equity ratio of 28.3% falls below industry median capital structures which typically maintain 35-45% equity ratios, indicating elevated financial leverage. Asia segment margin of 4.0% approaches industry benchmarks for offshore manufacturing operations, while Japan segment margin of 2.4% reflects domestic cost structure challenges common in the sector. The company's revenue exposure to automotive (53.2% of product mix) creates cyclicality aligned with automotive industry trends. Historical financial performance from benchmark data shows Book Value Per Share stable at 1,038.19 and prior period basic EPS of 27.75, with revenue trend declining from prior periods, suggesting cyclical downturn position relative to longer-term trajectory.
※ Industry: Electronics Manufacturing Services - Automotive/Industrial Focus, Source: Proprietary analysis of disclosed financial data and sector characteristics
Strong operating cash flow generation of 25.6B (+46.9% YoY) significantly exceeding net income demonstrates underlying business cash generation capability, with OCF/EBITDA of 2.0x and free cash flow of 19.2B providing financial flexibility for debt reduction, growth investment, and potential enhanced shareholder returns as profitability normalizes. The company's aggressive FY2026 guidance projecting 69.2% operating income growth on 10.9% revenue growth implies expectation for 90bp operating margin expansion to 2.6%, with achievement dependent on successful execution of gross margin improvement initiatives, operating leverage from volume recovery, favorable product mix shift toward higher-margin medical and industrial segments, and normalization of extraordinary charges and tax burden that suppressed FY2025 net income. Structural challenges requiring management attention include extended DSO of 78 days indicating need for enhanced collection processes and customer credit management, low gross margin of 10.5% limiting operating leverage and requiring product portfolio optimization toward higher value-added services, elevated debt/EBITDA of 6.51x and short-term debt concentration of 62.3% necessitating balance sheet deleveraging and debt maturity extension, and Asia geographic concentration of 56.0% creating dependency on regional demand stability while providing margin advantage that must be balanced with diversification considerations.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.